Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/SELLAS-LIFE-SCIENCES-GROU-39742686/nieuws/SELLAS-Life-Sciences-Group-Inc-Geeft-update-over-Fase-3-Regal-klinische-studie-voor-galinpepimut-S-45065471/?utm_source=whatsapp&utm_medium=social&utm_campaign=share